• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Imatinib and beyond--the new CML study IV. A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia.

作者信息

Berger U, Engelich G, Reiter A, Hochhaus A, Hehlmann R

机构信息

III Medizinische Universitätsklinik, Klinikum Mannheim, Universität Heidelberg, Wiesbadener Strasse 7-11, 68305 Mannheim, Germany.

出版信息

Ann Hematol. 2004 Apr;83(4):258-64. doi: 10.1007/s00277-003-0807-x. Epub 2003 Nov 29.

DOI:10.1007/s00277-003-0807-x
PMID:14648019
Abstract
摘要

相似文献

1
Imatinib and beyond--the new CML study IV. A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia.伊马替尼及其他——慢性粒细胞白血病新研究IV。新诊断慢性期慢性髓性白血病中伊马替尼与伊马替尼/α干扰素、伊马替尼/小剂量阿糖胞苷以及α干扰素治疗失败后伊马替尼的随机对照比较。
Ann Hematol. 2004 Apr;83(4):258-64. doi: 10.1007/s00277-003-0807-x. Epub 2003 Nov 29.
2
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.伊马替尼与干扰素和小剂量阿糖胞苷治疗新诊断慢性期慢性髓性白血病的比较
N Engl J Med. 2003 Mar 13;348(11):994-1004. doi: 10.1056/NEJMoa022457.
3
Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.甲磺酸伊马替尼治疗可改善新诊断的慢性期费城染色体阳性慢性髓性白血病患者的生存率：与历史数据比较。
Cancer. 2003 Dec 15;98(12):2636-42. doi: 10.1002/cncr.11831.
4
Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.伊马替尼与干扰素-α加小剂量阿糖胞苷治疗新诊断慢性期慢性髓性白血病患者的成本效益
Cancer. 2004 Dec 1;101(11):2574-83. doi: 10.1002/cncr.20694.
5
Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study.伊马替尼与干扰素α加小剂量阿糖胞苷治疗新诊断慢性期慢性髓性白血病患者的生活质量：IRIS研究结果
J Clin Oncol. 2003 Jun 1;21(11):2138-46. doi: 10.1200/JCO.2003.12.154.
6
Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.伊马替尼与干扰素-α加小剂量阿糖胞苷用于新诊断慢性期慢性髓性白血病患者的长期生存估计。
Cancer. 2004 Dec 1;101(11):2584-92. doi: 10.1002/cncr.20674.
7
Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia.伊马替尼用于新诊断的慢性期慢性髓性白血病患者。
Semin Hematol. 2003 Apr;40(2 Suppl 2):26-30. doi: 10.1053/shem.2003.50058.
8
High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group.高剂量伊马替尼与高剂量伊马替尼联合中剂量阿糖胞苷治疗初诊慢性期髓性白血病患者：荷兰-比利时 HOVON 研究组的一项随机 III 期试验。
Ann Hematol. 2013 Aug;92(8):1049-56. doi: 10.1007/s00277-013-1730-4. Epub 2013 Apr 10.
9
[Imatinib combination therapies--the new CML Study 4].伊马替尼联合疗法——新的慢性粒细胞白血病研究4
Dtsch Med Wochenschr. 2002 Oct 18;127(42):224-6.
10
[Imatinib mesylate (Glivec) in treatment of chronic phase chronic myeloid leukemia].甲磺酸伊马替尼（格列卫）治疗慢性期慢性髓性白血病
Vnitr Lek. 2004 Jan;50(1):21-3, 26-9.

引用本文的文献

1
Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies.髓系恶性肿瘤的固有免疫机制与免疫治疗
Biomedicines. 2021 Nov 6;9(11):1631. doi: 10.3390/biomedicines9111631.
2
[Analysis of correlation between plasma trough level and response of generic imatinib in the treatment of Chinese patients with chronic myeloid leukemia].[国产伊马替尼治疗中国慢性髓性白血病患者血浆谷浓度与疗效的相关性分析]
Zhonghua Xue Ye Xue Za Zhi. 2019 Nov 14;40(11):939-942. doi: 10.3760/cma.j.issn.0253-2727.2019.11.010.
3
Current management of chronic myeloid leukemia with tyrosine kinase inhibitors.
慢性髓性白血病的酪氨酸激酶抑制剂治疗现状。
Turk J Haematol. 2013 Sep;30(3):247-55. doi: 10.4274/Tjh.2013.0108. Epub 2013 Sep 5.
4
[Targeted therapy in the treatment of solid tumors and in hematology-oncology. Advances and disappointments].[实体瘤及血液肿瘤学治疗中的靶向治疗。进展与失望]
Internist (Berl). 2006 Jun;47(6):633-41. doi: 10.1007/s00108-006-1626-7.
5
[Molecular target structures in oncology].[肿瘤学中的分子靶点结构]
Internist (Berl). 2005 Aug;46(8):847-8, 850-4, 856-60. doi: 10.1007/s00108-005-1463-0.